NIOX®

medical devices

About

NIOX Group Plc is a UK-based medical technology company focused on developing and commercializing diagnostic devices for respiratory conditions, particularly asthma. Founded in 2000 and headquartered in Oxford, NIOX is a leader in fractional exhaled nitric oxide (FeNO) testing technology, which helps assess airway inflammation in asthma patients. The company's main product, the NIOX VERO®, is a portable and non-invasive device that measures FeNO levels quickly and reliably. This system includes the handheld device and necessary consumables, allowing healthcare professionals to efficiently perform asthma diagnostics and monitor treatment effectiveness. NIOX's technology has evolved significantly, making FeNO testing accessible in clinical practice worldwide. NIOX's products are utilized by physicians and healthcare providers globally, especially in the United States and Europe. The company is publicly traded on the London Stock Exchange AIM market under the ticker symbol “NIOX” and is committed to innovation in respiratory diagnostics through substantial investment in research and development.

Technologies

Outlook Microsoft Office 365 Google Cloud Hosting OneTrust Barracuda Networks

Keywords

feno testing niox asthma management asthma diagnosis biotechnology life sciences healthcare equipment & supplies medical device innovation asthma monitoring airway inflammation portable respiratory device digital health in respiratory care healthcare professional training feno biomarker device services airway inflammation detection medical device support respiratory care respiratory health technology asthma control tools respiratory biomarker testing asthma biomarker testing asthma management device airway inflammation monitoring healthcare technology medical equipment and supplies manufacturing b2b clinical support medical device support services digital health solutions

Location

Oxford, England, United Kingdom, OX4 4GB

Related Companies

Companies in the same industry